Group 1 - The company has added 14 new drugs for domestic production on its official website, which are mature products that have already obtained production licenses [2] - The company has not received any new production licenses as of 2025 and will continue to focus on new drug research and development [2] - The company aims to provide more high-quality treatment options for patients [2]